Ponzi Schemes 101: How You Can Avoid Being a Victim
Home Depot: Malware Hack Affected 56 Million Payment Cards
All Bets Are On for Britain's Next Royal Baby Name
Market Wrap: More Records Fall Thanks to Good Economic News
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.